Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Completed 16Withdrawn 2Terminated 2Recruiting 2Active not recruiting 2Unknown 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Myeloid 2

Conditions

Lymphoma 9Lymphoma, Large B-Cell, Diffuse 7Leukemia, Myeloid, Acute 7Leukemia 6Multiple Myeloma 5Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Lymphoma, Non-Hodgkin 4Lymphoma, Mantle-Cell 4Lymphoma, Follicular 4Hodgkin Disease 4Myelodysplastic Syndromes 3Lymphoma, Large-Cell, Immunoblastic 3Lymphoma, B-Cell, Marginal Zone 3Leukemia, Lymphocytic, Chronic, B-Cell 3Burkitt Lymphoma 3Sarcoma 2Retinoblastoma 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Leukemia, Myelomonocytic, Chronic 2Leukemia, Myeloid, Chronic-Phase 2Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2Central Nervous System Neoplasms 2Waldenstrom Macroglobulinemia 1Thrombocythemia, Essential 1Solid Tumors 1Small Cell Lung Carcinoma 1Sezary Syndrome 1Recurrence 1Primary Myelofibrosis 1Polycythemia Vera 1

Interventions

Cyclophosphamide 5nilotinib 4Cytarabine 4fludarabine 3Methotrexate 3Imatinib Mesylate 3Dasatinib 3Busulfan 3fludarabine phosphate 2Peripheral Blood Stem Cell Transplantation 2Idarubicin 2Granulocyte Colony-Stimulating Factor 2Filgrastim 2Cyclosporine 2AP 1903 reagent 2sargramostim 1ruxolitinib 1merphos 1amsonic acid 1Whole-Body Irradiation 1Vincristine 1Valproic Acid 1Thiotepa 1Tacrolimus 1Sirolimus 1Saline Solution 1Rituximab 1Prednisone 1Ondansetron 1Mesna 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Withdrawn × Leukemia, Myelogenous, Chronic, BCR-ABL Positive × Filgrastim × Clear all
NCT00446173 2015-08-25

Autologous Stem Cell Transplants for Chronic Myelogenous Leukemia

M.D. Anderson Cancer Center

Phase 2 Withdrawn
MyeloidOther hematologic neoplasm

Leukemia, Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT00002761 2012-11-19

Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia

Columbia University

Phase 1/2 Withdrawn
MyeloidOther hematologic neoplasm

Leukemia, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Chronic-Phase

Data powered by HemOnc (CC BY 4.0) Colophon âš¡